Toxoplasmosis is caused by Toxoplasma gondii (Nicolle et Manceaux, 1908), a coccidian protist (Apicomplexa). It has a strong predilection for infecting the central nervous system. Researchers have therefore investigated its association with several neurological and psychiatric disorders, including Alzheimer's disease, attention-deficit hyperactivity disorder, autism, bipolar disorder, cerebral palsy, depression, Guillain-Barre syndrome, multiple sclerosis, obsessive compulsive disorder, Parkinson's disease, personality disorders, and schizophrenia. Among these disorders the strongest evidence for a role of T. gondii exists for psychosis in general and schizophrenia in particular. This paper reviews the origins of this association, briefly summarises the current evidence in support, and discusses future research strategies.

Zobrazit více v PubMed

Ademe M., Kebede T., Teferra S., Alemayehu M., Girma F., Abebe T. 2022: Is latent Toxoplasma gondii infection associated with the occurrence of schizophrenia? A case-control study. PLoS One 17: e0270377. DOI

Alter M., Berman M., Kahana E. 1979: The year of the dog. Neurology 29: 1023-1026. DOI

Burgdorf K.S., Trabjerg B.B., Pedersen M.G., Nissen J., Banasik K., Pedersen O.B., Sørensen E., Nielsen K.R., Larsen M.H., Erikstrup C., Bruun-Rasmussen P., Westergaard D., Thørner L.W., Hjalgrim H., Paarup H.M., Brunak S., Pedersen C.B., Torrey E.F., Werge T., Mortensen P.B., Yolken R.H., Ullum H. 2019: Large-scale study of Toxoplasma and cytomegalovirus shows an association between infection and serious psychiatric disorders. Brain Behav. Immun. 79: 152-158. DOI

Chorlton S.D. 2017: Toxoplasma gondii and schizophrenia: a review of published RCTs. Parasitol. Res. 116: 1793-1799. DOI

Conejero-Goldberg C., Torrey E.F., Yolken R.H. 2003: Herpesviruses and Toxoplasma gondii in orbital frontal cortex of psychiatric patients. Schizophr. Res. 60: 65-69. DOI

Cook S.D, Dowling P.C. 1977: A possible association between house pets and multiple sclerosis. Lancet 309: 980-982. DOI

Cossu G., Preti A., Gyppaz D., Gureje O., Carta M.G. 2022: Association between toxoplasmosis and bipolar disorder: a systematic review and meta-analysis. J. Psychiatr. Res. 153: 284-291. DOI

Drapes T. 1894: On the alleged increase of insanity in Ireland. J. Ment. Sci. 40: 519-548. DOI

Dubey J.P. 2004: Toxoplasmosis - a waterborne zoonosis. Vet. Parasitol. 126: 57-72. DOI

Esshili A., Thabet S., Jemli A., Trifa F., Mechri A., Zaafrane F., Gaha L., Juckel G., Babba H., Bel Hadj Jrad B. 2016: Toxoplasma gondii infection in schizophrenia and associated clinical features. Psychiatry Res. 245: 327-332. DOI

Flegr J., Havlícek J., Kodym P., Malý M., Smahel Z. 2002: Increased risk of traffic accidents in subjects with latent toxoplasmosis: a retrospective case-control study. BMC Infect. Dis. 2: 11. DOI

Flegr J., Hrdý I. 1994: Influence of chronic toxoplasmosis on some human personality factors. Folia Parasitol. 41: 122-126.

Jones-Brando L., Torrey E.F., Yolken R. 2003: Drugs used in the treatment of schizophrenia and bipolar disorder inhibit the replication of Toxoplasma gondii. Schizophr. Res. 62: 237-244. DOI

Kannan G., Crawford J.A., Yang C., Gressitt K.L., Ihenatu C., Krasnova I.N., Cadet J.L., Yolken R.H., Severance E.G., Pletnikov M.V. 2016: Anti-NMDA receptor autoantibodies and associated neurobehavioral pathology in mice are dependent on age of first exposure to Toxoplasma gondii. Neurobiol. Dis. 91: 307-314. DOI

Konishi E. 1989: Annual change in immunoglobulin G and M antibody levels to Toxoplasma gondii in human sera. Microbiol. Immunol. 33: 403-411. DOI

Kozar Z. 1953: [Research and toxoplasmosis among mentally ill people.] Bull. Inst. Mar. Trop. Gdansk 5: 142-145. (In Polish.)

Kramer W. 1966: Frontiers of neurological diagnosis in acquired toxoplasmosis. Psychiatr. Neurol. Neurochir. 69: 43-54.

Ladee G.A. 1966: Diagnostic problems in psychiatry with regard to acquired toxoplasmosis. Psychiatr. Neurol. Neurochir. 69: 65-82.

Leweke F.M., Gerth C.W., Koethe D., Klosterkötter J., Ruslanova I., Krivogorsky B., Torrey E.F., Yolken R.H. 2004: Antibodies to infectious agents in individuals with recent onset schizophrenia. Eur. Arch. Psychiatry. Clin. Neurosci. 254: 4-8. DOI

McGrath J.J., Lim C.C.W., Saha S. 2023: Cat ownership and schizophrenia-related disorders and psychotic-like experiences: a systematic review and meta-analysis. Schizophr. Bull. 50: 489-495. DOI

Melzer T.C., Cranston H.J., Weiss L.M., Halonen S. K. 2010: Host cell preference of Toxoplasma gondii cysts in murine brain: a confocal study. J. Neuroparasitology 2010: 1: N100505. DOI

Mendoza-Larios L.A., García-Dolores F., Sánchez-Anguiano L.F., Antuna-Salcido E.I., Hernández-Tinoco J., Rocha-Salais A., Segoviano-Mendoza M.A., Sifuentes-Álvarez A., Alvarado-Esquivel C. 2023: Toxoplasma gondii infection of the central nervous system and suicide: a case-control study of decedents. Eur. J. Microbiol. Immunol. 13: 77-82. DOI

Montazeri M., Moradi E., Moosazadeh M., Hosseini S.H., Fakhar M. 2023: Relationship between Toxoplasma gondii infection and psychiatric disorders in Iran: a systematic review with meta-analysis. PLoS One 18: e0284954. DOI

Neville A.J., Zach S.J., Wang X., Larson J.J., Judge A.K., Davis L.A., Vennerstrom J.L., Davis P.H. 2015: Clinically available medicines demonstrating anti-Toxoplasma activity. Antimicrob. Agents Chemother. 59: 7161-7169. DOI

O'Hare A., Walsh D. 1974: Further data on activities of Irish psychiatric hospitals and units, 1965-1969. J. Irish Med. Assoc. 67: 57-63.

Rovira P., Gutiérrez B., Sorlózano-Puerto A., Gutiérrez-Fernández J., Molina E., Rivera M., Martínez-Leal R., Ibanez-Casas I., Martín-Laguna M.V., Rosa A., Torres-González F., Cervilla J.A. 2022: Toxoplasma gondii seropositivity interacts with catechol-o-methyltransferase Val105/158Met variation increasing the risk of schizophrenia. Genes (Basel) 13: 1088. DOI

Seligman C.G. 1929: Temperament, conflict and psychosis in a Stone Age population. Br. J. Med. Psychol. 9: 187-202. DOI

Steiner S. 1952: Multiple sclerosis and exposure to house pets. Neurology 2: 260-262.

Suzuki Y. 2002: Host resistance in the brain against Toxoplasma gondii. J. Infect Dis. 185: S58-65. DOI

Torrey E.F. 1966: A medical survey of the SaySay people in the Blue Nile Gorge. Ethiop. Med. J. 4: 155-165.

Torrey E.F. 1973: Is schizophrenia universal? An open question. Schizophr. Bull. 1: 53-59. DOI

Torrey E.F. 1980: Schizophrenia and Civilization. Aronson, New York, 244 pp.

Torrey E.F., Bartko J.J., Lun Z.R., Yolken R.H. 2007: Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis. Schizophr. Bull. 33: 729-736. DOI

Torrey E.F., McGuire M., O'Hare A., Walsh D., Spellman M.P. 1984: Endemic psychosis in western Ireland. Am. J. Psychiatry 141: 966-970. DOI

Torrey E.F., Miller J. 2002: The Invisible Plague: The Rise of Mental Illness from 1750 to the Present. Rutger University Press, Rutgers, New Jersey, 458 pp.

Torrey E.F., Peterson M.R. 1973: Slow and latent viruses in schizophrenia. Lancet 302: 22-24. DOI

Torrey E.F., Rawlings R., Yolken R.H. 2000: The antecedents of psychoses: a case-control study of selected risk factors. Schizophr. Res. 46: 17-23. DOI

Torrey E.F., Torrey B.B., Burton-Bradley B.G. 1974: The epidemiology of schizophrenia in Papua New Guinea. Am. J. Psychiatry 131: 567-573. DOI

Torrey E.F., Yolken R.H. 1995: Could schizophrenia be a viral zoonosis transmitted from house cats? Schizophr. Bull. 21: 167-171. DOI

Torrey E.F., Yolken R.H., Winfrey C.J. 1982: Cytomegalovirus antibody in cerebrospinal fluid of schizophrenic patients detected by enzyme immunoassay. Science 216: 892-894. DOI

Villegas E.N., Augustine S.A., Villegas L.F., Ware M.W., See M.J., Lindquist H.D., Schaefer F.W., Dubey J.P. 2010: Using quantitative reverse transcriptase PCR and cell culture plaque assays to determine resistance of Toxoplasma gondii oocysts to chemical sanitizers. J. Microbiol. Methods 81: 219-225. DOI

Walsh D., Walsh B. 1970: Mental illness in the Republic of Ireland - first admissions. J. Ir. Med. Assoc. 63: 365-370.

Wang H.L., Wang G.H, Li Q.Y., Shu C., Jiang M.S., Guo Y. 2006: Prevalence of Toxoplasma infection in first-episode schizophrenia and comparison between Toxoplasma-seropositive and Toxoplasma-seronegative schizophrenia. Acta Psychiatr. Scand. 114: 40-48. DOI

Xiao J., Bhondoekhan F., Seaberg E.C., Yang O., Stosor V., Margolick J.B., Yolken R.H., Viscidi R.P. 2021: Serological responses to Toxoplasma gondii and matrix antigen 1 predict the risk of subsequent toxoplasmic encephalitis in people living with Human Immunodeficiency Virus (HIV). Clin. Inf. Dis. 73: e2270-e2277. DOI

Xiao J., Yolken R.H. 2015: Strain hypothesis of Toxoplasma gondii infection on the outcome of human disease. Acta Physiol. 213: 828-845. DOI

Thirty years of studying latent toxoplasmosis: behavioural, physiological, and health insights